✦ LIBER ✦

The cleaved peptide of PAR1 is a more potent stimulant of platelet-endothelial cell adhesion than is thrombin

✍ Scribed by Claytor, R.Brannon; Michelson, Alan D.; Li, Jian-Ming; Frelinger, A.L.; Rohrer, Michael J.; Garnette, Charles S.C.; Barnard, Marc R.; Krueger, Lori A.; Furman, Mark I.

Book ID: 123337886
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 188 KB
Volume: 37
Category: Article
ISSN: 1097-6809
DOI: 10.1067/mva.2003.129

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The Cleaved Peptide of the Thrombin Rece

The Cleaved Peptide of the Thrombin Receptor is a Strong Platelet Agonist

✍ Mark I. Furman, Longbin Liu, Stephen E. Benoit, Richard C. Becker, Marc R. Barna 📂 Article 📅 1998 🏛 National Academy of Sciences 🌐 English ⚖ 986 KB

Platelet-Derived Growth Factor Is a Pote

Platelet-Derived Growth Factor Is a Potent Stimulator of Expression of Intercellular Adhesion Molecule-1 in Human Arterial Smooth Muscle Cells

✍ N. Morisaki; K. Takahashi; R. Shiina; M. Zenibayashi; M. Otabe; S. Yoshida; Y. S 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 309 KB

The dual thromboxane receptor antagonist

The dual thromboxane receptor antagonist and thromboxane synthase inhibitor EV-077 is a more potent inhibitor of platelet function than aspirin

✍ P. FONTANA; P. ALBERTS; K. S. SAKARIASSEN; H. BOUNAMEAUX; J.-P. MEYER; A. SANTAN 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 145 KB

TCT-500 Prasugrel Is A More Potent Plate

TCT-500 Prasugrel Is A More Potent Platelet Inhibitor Than Clopidogrel In Bivalirudin-Treated Patients. Comparative Effects of Two Thienopyridines On ADP And Thrombin Receptor Antagonism As Assessed By Aggregometry

✍ Kimmelstiel, Carey D.; Kuliopulos, Athan; Castaneda, Vilma; Stevenson, Ryan; Wei 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 67 KB

The novel Hsp-90 inhibitor SNX7081 is si

The novel Hsp-90 inhibitor SNX7081 is significantly more potent than 17-AAG against primary CLL cells and a range of haematological cell lines, irrespective of lesions in the TP53 pathway

✍ O. Giles Best; Nisha Singh; Cecily Forsyth; Stephen P. Mulligan 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 155 KB